Market Cap
US$837.6m
Last Updated
2021/02/27 23:36 UTC
Data Sources
Company Financials +
Executive Summary
Hanger, Inc. provides orthotic and prosthetic (O&P) services; and distributes O&P devices and components, manages O&P networks, and provides therapeutic solutions to patients and businesses in acute, post-acute, and clinic settings in the United States. More Details
Rewards
Risk Analysis
Snowflake Analysis
Solid track record and fair value.
Similar Companies
Share Price & News
How has Hanger's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: HNGR is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 6% a week.
Volatility Over Time: HNGR's weekly volatility (6%) has been stable over the past year.
Market Performance
7 Day Return
1.4%
HNGR
-0.4%
US Healthcare
-3.6%
US Market
1 Year Return
-4.7%
HNGR
25.3%
US Healthcare
36.4%
US Market
Return vs Industry: HNGR underperformed the US Healthcare industry which returned 25.8% over the past year.
Return vs Market: HNGR underperformed the US Market which returned 38.5% over the past year.
Shareholder returns
| HNGR | Industry | Market | |
|---|---|---|---|
| 7 Day | 1.4% | -0.4% | -3.6% |
| 30 Day | 4.4% | -2.3% | 0.9% |
| 90 Day | -6.9% | 0.7% | 6.7% |
| 1 Year | -4.7%-4.7% | 26.9%25.3% | 39.4%36.4% |
| 3 Year | 47.5%47.5% | 36.8%31.2% | 53.4%43.5% |
| 5 Year | 448.1%448.1% | 76.9%63.7% | 117.3%93.0% |
Long-Term Price Volatility Vs. Market
How volatile is Hanger's share price compared to the market and industry in the last 5 years?
Simply Wall St News
1 week ago | Simply Wall St
If You Had Bought Hanger (NYSE:HNGR) Shares Five Years Ago You'd Have Earned 67% Returns1 month ago | Simply Wall St
Here’s What’s Happening With Returns At Hanger (NYSE:HNGR)1 month ago | Simply Wall St
Hanger (NYSE:HNGR) Has A Pretty Healthy Balance SheetValuation
Is Hanger undervalued compared to its fair value and its price relative to the market?
20.31x
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: HNGR ($21.98) is trading above our estimate of fair value ($4.89)
Significantly Below Fair Value: HNGR is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: HNGR is good value based on its PE Ratio (20.3x) compared to the US Healthcare industry average (24.5x).
PE vs Market: HNGR is good value based on its PE Ratio (20.3x) compared to the US market (21.3x).
Price to Earnings Growth Ratio
PEG Ratio: HNGR is good value based on its PEG Ratio (0.6x)
Price to Book Ratio
PB vs Industry: HNGR is overvalued based on its PB Ratio (25.9x) compared to the US Healthcare industry average (3.5x).
Next Steps
Future Growth
How is Hanger forecast to perform in the next 1 to 3 years based on estimates from 2 analysts?
33.9%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: HNGR's forecast earnings growth (33.9% per year) is above the savings rate (2%).
Earnings vs Market: HNGR's earnings (33.9% per year) are forecast to grow faster than the US market (20.3% per year).
High Growth Earnings: earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: HNGR's revenue (9.4% per year) is forecast to grow slower than the US market (10.4% per year).
High Growth Revenue: HNGR's revenue (9.4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if HNGR's Return on Equity is forecast to be high in 3 years time
Next Steps
Past Performance
How has Hanger performed over the past 5 years?
95.8%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: HNGR has high quality earnings.
Growing Profit Margin: HNGR's current net profit margins (4%) are higher than last year (1.2%).
Past Earnings Growth Analysis
Earnings Trend: HNGR has become profitable over the past 5 years, growing earnings by 95.8% per year.
Accelerating Growth: HNGR's earnings growth over the past year (205.2%) exceeds its 5-year average (95.8% per year).
Earnings vs Industry: HNGR earnings growth over the past year (205.2%) exceeded the Healthcare industry 22.6%.
Return on Equity
High ROE: Whilst HNGR's Return on Equity (126.53%) is outstanding, this metric is skewed due to their high level of debt.
Next Steps
Financial Health
How is Hanger's financial position?
Financial Position Analysis
Short Term Liabilities: HNGR's short term assets ($363.5M) exceed its short term liabilities ($260.3M).
Long Term Liabilities: HNGR's short term assets ($363.5M) do not cover its long term liabilities ($660.1M).
Debt to Equity History and Analysis
Debt Level: HNGR's debt to equity ratio (1603%) is considered high.
Reducing Debt: HNGR's debt to equity ratio has increased from 228.6% to 1603% over the past 5 years.
Debt Coverage: HNGR's debt is well covered by operating cash flow (31.7%).
Interest Coverage: HNGR's interest payments on its debt are not well covered by EBIT (2.3x coverage).
Balance Sheet
Next Steps
Dividend
What is Hanger current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate HNGR's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate HNGR's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if HNGR's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if HNGR's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of HNGR's dividend in 3 years as they are not forecast to pay a notable one for the US market.
Next Steps
Management
How experienced are the management team and are they aligned to shareholders interests?
3.8yrs
Average management tenure
CEO
Vinit Asar (54 yo)
8.75yrs
Tenure
US$4,940,254
Compensation
Mr. Vinit K. Asar has been the Chief Executive Officer and President of Hanger Orthopedic Group Inc. (known as Hanger, Inc.) since May 21, 2012 and September 12, 2011 respectively. Mr. Asar served as the P...
CEO Compensation Analysis
Compensation vs Market: Vinit's total compensation ($USD4.94M) is above average for companies of similar size in the US market ($USD2.25M).
Compensation vs Earnings: Vinit's compensation has been consistent with company performance over the past year.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | 8.75yrs | US$4.94m | 2.09% $ 17.5m | |
| CFO & Executive VP | 6.08yrs | US$1.57m | 0.72% $ 6.1m | |
| Executive VP of Corporate Services & Chief Information Officer | 5.58yrs | US$826.16k | 0.23% $ 1.9m | |
| Senior VP | 11.67yrs | US$1.10m | 0.29% $ 2.4m | |
| VP & Chief Accounting Officer | 3.83yrs | no data | 0.16% $ 1.3m | |
| VP of Corporate Finance & Treasurer | 5.75yrs | no data | no data | |
| Vice President of Treasury & Investor Relations | 3.08yrs | no data | no data | |
| Senior VP & Chief Compliance Officer | 2.33yrs | no data | 0.085% $ 711.2k | |
| Vice President of Public Relations & Communications | no data | no data | no data | |
| Senior VP & Chief Human Resources Officer | 2.58yrs | no data | 0.076% $ 634.8k | |
| Senior VP & Chief Clinical Officer | 2.33yrs | no data | 0.11% $ 907.3k | |
| President of Products & Services | 1.17yrs | no data | 0.047% $ 390.3k |
3.8yrs
Average Tenure
54yo
Average Age
Experienced Management: HNGR's management team is considered experienced (3.8 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | 8.75yrs | US$4.94m | 2.09% $ 17.5m | |
| Independent Director | 10.75yrs | US$240.01k | 0.12% $ 964.7k | |
| Independent Non-Executive Chairman | 3.08yrs | US$335.01k | 0.16% $ 1.3m | |
| Independent Director | 3.25yrs | US$245.01k | 0.040% $ 333.0k | |
| Director Emeritus | 3.08yrs | no data | no data | |
| Independent Director | 7yrs | US$235.01k | 0.16% $ 1.4m | |
| Independent Director | 6.08yrs | US$225.01k | 0.12% $ 1.0m | |
| Independent Director | 5.75yrs | US$225.01k | 0.14% $ 1.2m | |
| Independent Director | 3.25yrs | US$225.01k | 0.034% $ 286.1k | |
| Independent Director | 6.5yrs | US$225.01k | 0.15% $ 1.2m | |
| Director | 0.42yr | no data | no data |
5.8yrs
Average Tenure
66yo
Average Age
Experienced Board: HNGR's board of directors are considered experienced (5.8 years average tenure).
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 2.1%.
Top Shareholders
Company Information
Hanger, Inc.'s company bio, employee growth, exchange listings and data sources
Key Information
- Name: Hanger, Inc.
- Ticker: HNGR
- Exchange: NYSE
- Founded: 1861
- Industry: Health Care Facilities
- Sector: Healthcare
- Market Cap: US$837.644m
- Shares outstanding: 38.11m
- Website: https://www.hanger.com
Number of Employees
Location
- Hanger, Inc.
- 10910 Domain Drive
- Suite 300
- Austin
- Texas
- 78758
- United States
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| HNGR | NYSE (New York Stock Exchange) | Yes | Common Shares | US | USD | Feb 1986 |
Biography
Hanger, Inc. provides orthotic and prosthetic (O&P) services; and distributes O&P devices and components, manages O&P networks, and provides therapeutic solutions to patients and businesses in acute, post-...
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2021/02/27 23:36 |
| End of Day Share Price | 2021/02/26 00:00 |
| Earnings | 2020/09/30 |
| Annual Earnings | 2019/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.